4.5 Article

Disease-Causing Mutations Improving the Branch Site and Polypyrimidine Tract: Pseudoexon Activation of LINE-2 and Antisense Alu Lacking the Poly(T)-Tail

Journal

HUMAN MUTATION
Volume 30, Issue 5, Pages 823-831

Publisher

WILEY
DOI: 10.1002/humu.20969

Keywords

long interspersed nuclear element; Alu; hyperphenylalaninemia; tetrahydrobiopterin; PTS

Funding

  1. Swiss National Foundation [310000-107500]
  2. Juvenile Diabetes Research Foundation International [1-2008-047]

Ask authors/readers for more resources

Cryptic exons or pseudoexons are typically activated by point mutations that create GT or AG dinuclectides of new 5' or 3' splice sites in introns, often in repetitive elements. Here we describe two cases of tetrahydrobiopterin deficiency caused by mutations improving the branch point sequence and polypyrimidine tracts of repeal containing pseudoexons in the PTS gene. In the first case, WC demonstrate a novel pall of antisense Alu exonization, resulting from an intronic deletion that removed the poly(T),tail of antisense AluSq. The deletion brought a favorable branch point sequence within proximity of the pseudoexon 3' splice site and removed an upstream AG dinucleotide required for the 3' splice site repression on normal alleles. New Alu exons can thus arise in the absence of poly(T)-tails that facilitated inclusion of most transposed elements in mRNAs by serving as polypyrimidine tracts, highlighting extraordinary flexibility of Alu repeats in shaping intron-exon structure. In the other case, a PTS pseudoexon was activated by an A > T substitution 9 nt upstream of its 3' splice site in a LINE,2 sequence, providing the first example of a disease-causing exonization of the most ancient interspersed repeat. These observations expand the spectrum of mutational mechanisms that introduce repetitive sequence.,; in mature transcripts and illustrate the importance of intronic mutations in alternative splicing and phenotypic variability of hereditary disorders. Hum Mutat 30:823-831, 2009. (C) 2009 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available